Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kullmann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Neurological Disorders|July 2, 2016
Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS surveyRocco Haase, Jennifer S Kullmann, Tjalf Ziemssen
Journal of Neuroendocrinology|January 17, 2015
Insulin action in the human brain: evidence from neuroimaging studiesS Kullmann, M Heni, A Fritsche, et al.
Patient Preference and Adherence|June 18, 2020
Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational StudyDirk Schriefer, Rocco Haase, Jennifer S Kullmann, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 14, 2015
Compromised white matter integrity in obesityS Kullmann, F Schweizer, R Veit, et al.
Therapeutic Advances in Neurological Disorders|May 29, 2024
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over timeBoris-Alexander Kallmann, Georg Zu Eulenburg, Jennifer S Kullmann, et al.
Psychoneuroendocrinology|February 12, 2013
Salivary α-amylase response to endotoxin administration in humansJan-Sebastian Grigoleit, Jennifer S Kullmann, Reiner Oberbeck, et al.
Therapeutic Advances in Neurological Disorders|April 5, 2019
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational studyBoris A Kallmann, Klaus Tiel-Wilck, Jennifer S Kullmann, et al.
Therapeutic Advances in Neurological Disorders|May 28, 2021
Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment statusBoris A Kallmann, Stefan Ries, Jennifer S Kullmann, et al.
Pain|October 9, 2013
Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry studySigrid Elsenbruch, Julia Schmid, Jennifer S Kullmann, et al.
International Journal of Obesity (2005)|June 10, 2014
Attentional impulsivity in binge eating disorder modulates response inhibition performance and frontal brain networksM A Hege, K T Stingl, S Kullmann, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Neurological Disorders|July 2, 2016
Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS surveyRocco Haase, Jennifer S Kullmann, Tjalf Ziemssen
Journal of Neuroendocrinology|January 17, 2015
Insulin action in the human brain: evidence from neuroimaging studiesS Kullmann, M Heni, A Fritsche, et al.
Patient Preference and Adherence|June 18, 2020
Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational StudyDirk Schriefer, Rocco Haase, Jennifer S Kullmann, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 14, 2015
Compromised white matter integrity in obesityS Kullmann, F Schweizer, R Veit, et al.
Therapeutic Advances in Neurological Disorders|May 29, 2024
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over timeBoris-Alexander Kallmann, Georg Zu Eulenburg, Jennifer S Kullmann, et al.
Psychoneuroendocrinology|February 12, 2013
Salivary α-amylase response to endotoxin administration in humansJan-Sebastian Grigoleit, Jennifer S Kullmann, Reiner Oberbeck, et al.
Therapeutic Advances in Neurological Disorders|April 5, 2019
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational studyBoris A Kallmann, Klaus Tiel-Wilck, Jennifer S Kullmann, et al.
Therapeutic Advances in Neurological Disorders|May 28, 2021
Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment statusBoris A Kallmann, Stefan Ries, Jennifer S Kullmann, et al.
Pain|October 9, 2013
Visceral sensitivity correlates with decreased regional gray matter volume in healthy volunteers: a voxel-based morphometry studySigrid Elsenbruch, Julia Schmid, Jennifer S Kullmann, et al.
International Journal of Obesity (2005)|June 10, 2014
Attentional impulsivity in binge eating disorder modulates response inhibition performance and frontal brain networksM A Hege, K T Stingl, S Kullmann, et al.
Pageof 2